Skip to main content

Table 2 Operative data and postoperative complications of LDKT recipients

From: Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation

   Patient groups according to moon phases/moon sign Libra    P-value*
  n (%) a New moon Waxing moon Full moon Waning moon Moon sign Libra  
Number of patients 278 (100.0) 33 (100.0) 111 (100.0) 32 (100.0) 102 (100.0) 17 (100.0)  
Duration of operation (min.) b 160 [65–345] 155 [120–345] 160 [90–280] 155 [65–295] 160 [99–335] 160 [120–265] 0.532
Graft placement c:
 R-L 133 (47.8) 16 (48.4) 58 (52.3) 17 (53.1) 42 (41.2) 11 (64.7) 0.358
 L-R 91 (32.7) 13 (39.4) 32 (28.8) 9 (28.1) 37 (36.3) 4 (23.5) 0.530
 L-L 23 (8.3) 3 (9.1) 8 (7.2) 2 (6.3) 10 (9.8) 1 (5.9) 0.883
 R-R 31 (11.2) 2 (6.1) 12 (10.8) 4 (12.5) 13 (12.7) 1 (5.9) 0.756
Hospital length of stay (days) b 18 [1–65] 20 [7–43] 17.5 [5–65] 16.5 [7–58] 18 [1–53] 21 [6–32] 0.851
General complications during inhospital stay d,e 12 (4.3) 1 (3.0) 4 (3.6) 2 (6.3) 5 (4.9) 0 (0) 0.887
Surgical complications during inhospital stay f 59 (21.2) 10 (30.3) 23 (20.7) 6 (18.8) 20 (19.6) 5 (29.4) 0.589
Relaparotomy 49 (17.6) 8 (16.2) 18 (16.2) 6 (18.8) 17 (16.7) 4 (23.5) 0.744
Rejection episodes g 56 (20.1) 8 (24.2) 24 (21.6) 8 (25.0) 16 (15.7) 1 (5.9) 0.527
Delayed graft function h 26 (9.4) 1 (3.0) 11 (9.9) 2 (6.3) 12 (11.8) 0 (0) 0.447
Long-term surgical complications i (>90 days) 25 (9.0) 2 (6.1) 11 (9.9) 3 (9.4) 9 (8.8) 1 (5.9) 0.925
Mortality:
 (<30 days) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)  
 (<90 days) 1 (0.4) 0 (0) 1 (0.9) 0 (0) 0 (0) 0 (0)  
Graft loss:
 (<30 days) 4 (1.4) 0 (0) 2 (1.8) 1 (3.1) 1 (1.0) 1 (5.9)  
 (<90 days) 5 (1.8) 0 (0) 2 (1.8) 1 (3.1) 1 (1.0) 1 (5.9)  
  1. KT kidney transplantation, LDKT living donor kidney transplantation
  2. * p-values are calculated for moon phases only.
  3. avalues are number (percentage) unless indicated otherwise
  4. bvalues are median [range]
  5. cL = left, R = right, the first letter indicates the kidney, the second letter indicates the placement side
  6. dincluding cardiac events, respiratory events, multiorgan failure and gastrointestinal bleeding
  7. esome patients had more than one complication
  8. fincluding vascular complications, ureteral complications, events of graft rupture and dislocation, developmant of lymphocele, peritonitis, postoperative hemorrhage, events of fascial dehiscence, superficial and deep wound infection
  9. gall rejection episodes were biopsy-proven
  10. hneed for dialysis in the first 7 days after transplant and/or the presence of biopsy-proven acute tubular necrosis (ATN)
  11. iincluding vascular, urologic complications, fascial dehiscence, hernia